首页> 外文期刊>European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V >Evaluation of paracetamol suppositories by a pharmacopoeial dissolution test - comments on methodology.
【24h】

Evaluation of paracetamol suppositories by a pharmacopoeial dissolution test - comments on methodology.

机译:通过药典溶出度试验评估扑热息痛栓剂-方法论评论。

获取原文
获取原文并翻译 | 示例
           

摘要

Ph.Eur. and BP have introduced a dissolution apparatus for suppositories. Suitability of the apparatus for quality control of paracetamol suppositories was evaluated and the effect of experimental conditions on dissolution profiles was studied. Paracetamol suppositories containing 80-500 mg of the drug, on fatty base, were obtained from four manufacturers (A, B, C, D). The diffusion cell was modified by incorporation of an in-built thermoprobe and large difference (up to 1.7 degrees C) between temperature in the water-bath and in the dissolution chamber was observed. This effect was avoided by increasing the length of tubing immersed in the thermostat at the inlet of the cell. The most reproducible results were observed for A and C suppositories, however from suppository C the total dose of paracetamol was released after 3.5-4.5 h while the release from suppository A was slow with only 40-87% of the total dose liberated during 6 h. Suppositories B did not melt at 37 degrees C and less than 5% of the drug was released. Fast release was observed after melting when the temperature was elevated to 39.5 degrees C. The results demonstrate clearly that essentially complete melting of a suppository in the dissolution chamber is required for an appropriate dissolution of paracetamol in vitro. Disintegration time, softening time, drop point and particle size of the suspended drug were measured and the relevance of these parameters for dissolution behaviour of the preparations was discussed.
机译:博士BP和BP引入了栓剂溶出仪。评价了对乙酰氨基酚栓剂质量控制装置的适用性,并研究了实验条件对溶出曲线的影响。从四个生产商(A,B,C,D)获得以脂肪为基础的含有80-500 mg药物的扑热息痛栓剂。通过加入内置的热探针对扩散池进行修改,并观察到水浴和溶解室之间的温度相差很大(最高1.7摄氏度)。通过增加浸没在电池进口处恒温器中的管道的长度可以避免这种影响。观察到A和C栓剂的重现性最高,但是从栓剂C中,对乙酰氨基酚的总剂量在3.5-4.5 h后释放,而从栓剂A中的释放缓慢,在6 h内仅释放了总剂量的40-87% 。栓剂B在37℃下不熔化,并且少于5%的药物被释放。融化后,当温度升高至39.5摄氏度时,观察到快速释放。结果清楚地表明,对乙酰氨基酚在体外的适当溶解需要在溶解室内将栓剂基本完全融化。测量了悬浮药物的崩解时间,软化时间,滴点和粒径,并讨论了这些参数与制剂溶解行为的相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号